ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 246

Bone Mineral Density and the Risk of Knee Osteoarthritis: The Johnston County Osteoarthritis Project

Kamil E. Barbour1, Jennifer M. Hootman2, Charles G. Helmick3, Louise Murphy4, Jordan B. Renner5 and Joanne M. Jordan6, 1Centers for Disease Control and Prevention, Atlanta, GA, 2Division of Population Health, Centers for Disease Control and Prevention, Kennesaw, GA, 3National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, 4Division of Population Health, CDC, Atlanta, GA, 5University of North Carolina Department of Radiology, Chapel Hill, NC, 6Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: bone density and risk, OA

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Risk Factors for and Sequelae of Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: There is credible evidence that high bone mineral density (BMD) is associated with an increased risk of incident radiographic osteoarthritis (ROA) of the knee. However, less is known about the relationship of BMD and the outcome with greater clinical and public health relevance, incident symptomatic ROA (sROA).

Methods:  Using data (N=951) from the Johnston County Osteoarthritis Project’s first (1999-2004) and second follow-up (2005-2010), we examined the association between BMD and both incident knee ROA and sROA among participants aged ≥45 years. Total hip BMD at baseline was measured using dual-energy X-ray absorptiometry. Participants were grouped into sex-specific BMD quartiles because of large sex-specific differences in BMD.  Incident knee ROA was defined as development of a Kellgren-Lawrence grade of ≥2 in a knee at second follow-up. Incident knee sROA was defined as onset of both ROA and symptoms in at least one knee at second follow-up. Weibull regression modeling, which accounted for interval censored data, was used to estimate hazard ratios (HR) and 95% confidence intervals (95% CIs). Multivariate models adjusted for age, BMI, sex, race, education, smoking, physical activity, and history of knee injury. 

Results: Median follow-up time was 6.8 (range=4.0-10.2) years. Compared with participants in the lowest BMD quartile, the multivariable adjusted HRs (95% CIs) of sROA for participants in the second, third, and highest quartiles of total hip BMD were 1.4 (0.9 to 2.4), 1.7 (1.1 to 2.7), and 1.6 (1.02 to 2.5), respectively, p trend = 0.03. Risk of sROA risk did not vary by total hip BMD quartiles, nor was the test of trend significant across BMD quartiles (p trend=0.23). 

Conclusion: Although high levels of BMD may significantly increase one’s risk of knee ROA, we found no evidence of an association between BMD and the more clinically relevant outcome of knee sROA.  These findings suggest that adults can achieve and maintain a healthy BMD without the tradeoff of increasing their risk of the painful and potentially debilitating outcome of sROA.


Disclosure:

K. E. Barbour,
None;

J. M. Hootman,
None;

C. G. Helmick,
None;

L. Murphy,
None;

J. B. Renner,
None;

J. M. Jordan,

Trinity Partners, Inc. ,

5,

Osteoarthritis Research Society International,

6,

Chronic Osteoarthritis Management Initiative of US Bone and Joint Initiative,

6,

Samumed,

5,

Interleukin Genetics, Inc. ,

5,

Algynomics, Inc. ,

1.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-mineral-density-and-the-risk-of-knee-osteoarthritis-the-johnston-county-osteoarthritis-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology